Cardlytics Carries On Income Contraction Among Failing Business Economics (NASDAQ: CDLX)

.Financial author highly recommends selling Cardlytics, Inc. as a result of decreasing unit business economics, revenue problems, as well as adverse economic styles. Click on for this CDLX update.